Europe — EMA
Obgemsa (Vibegron)
Vibegron, the active ingredient in Obgemsa, is a beta‑3 adrenergic receptor agonist presented as a oral tablet for oral use. It treats overactive bladder symptoms in adults.
Request sourcing
What is Vibegron?
Vibegron, the active ingredient in Obgemsa, is a beta‑3 adrenergic receptor agonist presented as a oral tablet for oral use. It treats overactive bladder symptoms in adults. GNH USA supplies Obgemsa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Obgemsa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Vibegron used for?
Obgemsa is a beta‑3 adrenergic agonist that improves bladder storage function by relaxing the detrusor muscle.
- Overactive bladder: Reduces frequency, urgency and the need to urinate often through muscle relaxation. - Urinary urgency: Helps the patient gain better control over urinary urgency. - No other approved indications by the‑
What are the side effects of Vibegron?
The … … … … ...
What precautions apply to Vibegron?
…
